MA’s ZEPHYR Phase 2 trial in schizophrenia Last patient visit completed for ML-004’s IRIS Phase 2 trial in autism spectrum disorderTopline results from both Phase 2 trials expected by mid-August 2026 ...
Even though facial recognition templates are more secure than photos -- which anyone can capture and manipulate -- templates, ...
Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced that it will deliver more than 40 scientific data ...
Part of the Grand Green Osaka development, Umekita Forest will feature a 3m-tall waterfall and a biodiverse ecosystem ...
Eye color is shaped by a complex interplay of genetics, microscopic iris structure, and the way light scatters within the eye. While lighting, pupil size, and clothing can make eyes appear to change ...
The Met Gala 2026 is shaping up to be one of the most anticipated nights on the fashion calendar, where imagination, ...
A bill that passed the Senate on Tuesday would guarantee pensions for Alaska’s public-sector workers for the first time in 20 ...
A remarkable exhibition at London’s British Museum traces the 1,000-year history, evolution and influence of Japan’s famed warrior class.
UIDAI has once again clarified that the Aadhaar card is valid solely as a form of identity (ID), but it cannot be considered conclusive proof of one's Date of Birth. This clarification was issued ...